Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Joshua Stolker, MD

Patients with type 2 diabetes face a higher risk of cardiovascular morbidity and mortality than adults without diabetes. How does this understanding specifically affect the way cardiologists manage their patients with type 2 diabetes? Joining Dr. Charles Turck to explore recently updated recommendations and their impacts on cardiology practice is interventional cardiologist Dr. Joshua Stolker.

To view the 2020 American College of Cardiology Expert Consensus Decision Pathway click here.

Novo Nordisk is a registered trademark of Novo Nordisk A/S.

© 2021 Novo Nordisk All rights reserved. US20DI00435 February 2021